Actively Recruiting
Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.
Led by University of Thessaly · Updated on 2025-05-28
200
Participants Needed
2
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to measure the levels of serum tryptase and correlate them with the severity of coronary artery disease in study population. In addition, it will evaluate the usability of tryptase levels as a prognostic biomarker for future cardiovascular events.
CONDITIONS
Official Title
Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female subjects aged 18 - 85 years old
- Clinical symptoms of angina classified by the Canadian Cardiovascular Score (CCS score)
- Positive SPECT scan for myocardial ischemia
You will not qualify if you...
- Acute Coronary Syndrome within 4 weeks before coronary catheterization
- Previous Percutaneous Coronary Angioplasty
- Previous Coronary Artery Bypass Graft
- Active allergy symptoms such as asthma or urticaria
- Mastocytosis
- Hypereosinophilia
- Autoimmune disease
- Cancer
- Kidney failure
- Myelodysplastic Syndrome
- Refusal to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
417 Military Hospital NIMTS
Athens, Attica, Greece, 11521
Actively Recruiting
2
Larisa University Hospital
Larissa, Thessaly, Greece, 41334
Actively Recruiting
Research Team
F
Fotios Skoufis, MD Medicine
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here